What Is CBD? The Complete Beginner's Guide

What Is CBD (Cannabidiol)?

CBD, short for cannabidiol, is one of over 100 naturally occurring compounds called cannabinoids found in the cannabis plant. It was first isolated by chemist Roger Adams in 1940, but its structure wasn't fully described until Raphael Mechoulam's work in the 1960s — research that also led to the discovery of THC.

Here's the critical distinction: CBD is not psychoactive in the way THC is. It won't get you high, alter your perception, or impair your judgment. This is because CBD doesn't bind strongly to the CB1 receptors in the brain — the receptors THC activates to produce its intoxicating effects.

Most CBD products are derived from hemp, a variety of Cannabis sativa bred to contain very low levels of THC (below 0.2% in the EU, 0.3% in the US). Hemp and marijuana are the same species, but they're functionally very different — much like how a Chihuahua and a Great Dane are both dogs.

CBD is typically extracted from the flowers and leaves of the hemp plant using methods like supercritical CO₂ extraction (considered the gold standard for purity) and then formulated into oils, capsules, topicals, and other products.

---

How Does CBD Work? The Endocannabinoid System

To understand CBD, you need to understand the system it interacts with: the endocannabinoid system (ECS).

Discovered in the early 1990s by researchers studying THC, the ECS is a complex cell-signaling system present throughout your body. It plays a role in regulating a wide range of processes, including sleep, mood, appetite, pain perception, immune response, and memory.

The ECS has three core components:

• Endocannabinoids — molecules your body produces naturally, similar in structure to plant cannabinoids. The two key endocannabinoids are anandamide (often called the "bliss molecule") and 2-AG.
• Cannabinoid receptors — found on the surface of cells throughout the body. CB1 receptors are concentrated in the central nervous system; CB2 receptors are more common in the immune system and peripheral tissues.
• Enzymes — primarily FAAH and MAGL, which break down endocannabinoids after they've done their job.

CBD's interaction with the ECS is more subtle than THC's. Rather than binding directly to CB1 or CB2 receptors, CBD appears to work through several indirect mechanisms:

1. Inhibiting FAAH — the enzyme that breaks down anandamide. By slowing this process, CBD may increase your natural anandamide levels, which is associated with improved mood and reduced anxiety.
2. Modulating receptors — CBD acts as an allosteric modulator of cannabinoid receptors, meaning it changes how they respond to other compounds without directly activating them.
3. Interacting with non-cannabinoid receptors — CBD also influences serotonin receptors (5-HT1A, linked to anxiety and mood), TRPV1 receptors (involved in pain perception and inflammation), and PPARγ receptors (involved in metabolism and inflammation).

This multi-target approach is one reason CBD shows potential across such a wide range of conditions — but it's also why the science is complex and still evolving.

---

Types of CBD Products

CBD comes in several formats, each with different absorption rates, convenience factors, and use cases.

CBD oils and tinctures are the most popular format in Europe. Taken sublingually (under the tongue), they offer relatively fast absorption because the CBD enters the bloodstream through the mucous membranes, bypassing the digestive system.

CBD capsules and softgels offer precise, pre-measured doses and are tasteless and easy to take. However, because they pass through the digestive system (first-pass metabolism), bioavailability is lower. Onset takes 30 to 90 minutes, but effects may last longer.

CBD topicals — creams, balms, and salves — are applied directly to the skin and are primarily used for localised discomfort, inflammation, or skin conditions. They don't enter the bloodstream in significant amounts, so they work locally rather than systemically.

CBD edibles and gummies are popular for convenience and taste but have the same bioavailability limitations as capsules. The gummy format is the fastest-growing segment in the European market, particularly popular with consumers under 35.

CBD vapes offer the fastest onset and highest bioavailability, but they come with the respiratory health risks associated with any form of inhalation. We generally don't recommend vaping as a first-choice delivery method.

For most beginners, sublingual oil is the best starting point — it offers a good balance of bioavailability, dosing flexibility, and speed of onset. For a deeper comparison, see our guide to CBD Oil vs CBD Capsules.

---

Full-Spectrum, Broad-Spectrum, and Isolate: What's the Difference?

Not all CBD products are the same. The type of extract used determines what other compounds from the hemp plant are present alongside CBD, and this significantly affects how the product works.

Full-spectrum CBD contains CBD plus all other naturally occurring cannabinoids (including trace amounts of THC, below 0.2% in the EU), terpenes, flavonoids, and other plant compounds. Many researchers believe these compounds work together synergistically in what's known as the entourage effect — a concept first proposed by Raphael Mechoulam and supported by research showing that whole-plant extracts can be more effective than isolated cannabinoids (Russo, 2019 — British Journal of Pharmacology).

Broad-spectrum CBD retains most of the hemp plant's compounds but with THC completely removed. This is a good middle ground for people who want the potential entourage effect benefits but need to avoid THC entirely — for example, due to workplace drug testing policies.

CBD isolate is pure CBD (typically 99%+) with no other cannabinoids, terpenes, or plant compounds. It's flavourless and offers precise dosing, but may be less effective than full-spectrum extracts for many people. Research suggests CBD isolate may have a "bell-shaped" dose-response curve, meaning its effectiveness can decrease at very high doses — a limitation not seen as clearly with full-spectrum products (Gallily et al., 2015 — Pharmacology & Pharmacy).

For most people, full-spectrum CBD offers the best results. We dig deeper into this topic in our guide to Full-Spectrum vs Broad-Spectrum vs CBD Isolate.

---

What Does the Research Say?

Let's be honest: CBD research is promising but still maturing. Much of the strongest evidence comes from animal studies and small human trials. That said, some areas have more robust data than others.

What has strong evidence

Epilepsy is the one area where CBD has been convincingly proven effective. Epidiolex (a pharmaceutical-grade CBD product) was approved by the FDA in 2018 and the EMA in 2019 for the treatment of severe epilepsy disorders (Dravet syndrome, Lennox-Gastaut syndrome). This is prescription medication, not a supplement — but it demonstrates CBD's genuine pharmacological activity. (Devinsky et al., 2017 — NEJM)

What has moderate evidence

Anxiety is perhaps the most promising area for consumer CBD use. A 2019 study published in The Permanente Journal followed 72 adults and found that anxiety scores improved in 79.2% of participants within the first month of CBD use, with effects sustained over the study period (Shannon et al., 2019). Multiple smaller studies and reviews support CBD's anxiolytic effects, likely mediated through serotonin 5-HT1A receptor activity.

Sleep research often overlaps with anxiety. The same Shannon et al. study found that sleep scores improved in 66.7% of participants, though results fluctuated over time. CBD appears to improve sleep primarily by addressing the anxiety and stress that interfere with it, rather than acting as a direct sedative.

Pain and inflammation have been studied primarily in animal models, which show consistent anti-inflammatory and analgesic effects. Human evidence is more limited, though a 2020 review in the Journal of Clinical Medicine found encouraging results for chronic pain, particularly when CBD was used alongside THC in full-spectrum formulations (Argueta et al., 2020).

What needs more research

Claims around CBD for skin conditions, neuroprotection, cardiovascular health, and gut health remain preliminary. Animal studies and mechanistic research are interesting, but we don't yet have sufficient human clinical trials to make confident recommendations in these areas.

The bottom line: CBD is not a cure-all, and anyone claiming otherwise is overselling it. But it's also not a placebo — there's genuine pharmacological activity and a growing body of evidence, particularly for anxiety and sleep. The key is to have realistic expectations.

---

Is CBD Legal in Europe?

This is where things get complicated — and where a European-specific guide becomes essential.

The EU Novel Food situation

Under EU regulation, CBD extracts are classified as a Novel Food — meaning they weren't significantly consumed in the EU before May 1997 and therefore require pre-market authorisation before they can be legally sold as food or food supplements.

As of early 2026, no CBD product has received full Novel Food authorisation in the EU. Several applications are pending, but the European Food Safety Authority (EFSA) has set an extremely high bar. In September 2025, EFSA proposed a provisional safe daily intake of just 2mg CBD per day for adults — a figure that would make most current products non-compliant if formally adopted. (EFSA CBD Safety Assessment, 2025)

EFSA has also stated that no safe use has been established for people under 25, pregnant or breastfeeding women, or those taking other medications.

The UK situation

The UK's Food Standards Agency (FSA) operates independently from EFSA and has been slightly more pragmatic. CBD products that were on the UK market before 2020 and submitted Novel Food applications by March 2021 are permitted to remain on sale pending review. The first UK-approved CBD food products are expected to arrive on shelves in 2026.

Country-by-country reality

Despite the EU-wide Novel Food classification, enforcement varies dramatically between member states:

• Netherlands — Moderate tolerance. CBD products are widely available in shops and online. CBD oil is sold as a supplement, though technically unapproved under Novel Food law.
• Germany — Stricter enforcement since 2024. Frequent product recalls and fines for unapproved CBD foods. Topical products remain widely available.
• Switzerland — The most permissive European market, allowing up to 1% THC. CBD flowers, oils, and supplements are sold in a fully regulated multi-sector market.
• France — CBD products are legal but the flower market was restricted in 2024. THC limit of 0.0% was challenged in court.
• Italy — Volatile. Emergency decrees in 2025 classified hemp flower as a narcotic, though CBD oils remain available.
• Austria, Czech Republic — More liberal domestic frameworks supporting a wide range of CBD products.

What this means for you as a consumer

CBD products are widely available across Europe, and buying them is not illegal for consumers. The regulatory issue is primarily on the supply side — brands are technically selling without Novel Food authorisation in most cases. As a buyer, focus on purchasing from brands that prioritise transparency, third-party lab testing, and compliance with their national regulations.

---

How to Choose Quality CBD

The lack of full EU regulation means quality varies enormously. Here's what to look for when choosing a CBD product:

Third-party lab testing (Certificates of Analysis) is non-negotiable. Reputable brands make their COAs publicly available, showing exact cannabinoid content, THC levels, and testing for contaminants like heavy metals, pesticides, and residual solvents. If a brand doesn't share its lab results, move on.

Extraction method matters. Supercritical CO₂ extraction is considered the cleanest method, producing pure extracts without harmful solvent residues. Ethanol extraction is also acceptable. Avoid products extracted with butane or other hydrocarbons.

Hemp source and farming practices affect the final product. Look for organically grown European hemp. The soil and growing conditions matter because hemp is a bioaccumulator — it absorbs substances from the soil, including heavy metals and pesticides.

Clear labelling should tell you exactly how much CBD is in the product (in milligrams per serving and per container), the type of extract (full-spectrum, broad-spectrum, or isolate), and all other ingredients. Be cautious of brands that only list "hemp extract" without specifying CBD content.

Brand transparency and reputation can be assessed through independent review platforms, verification services, and how openly a company communicates about its sourcing, manufacturing, and testing processes.

---

Side Effects and Safety

CBD is generally well-tolerated in humans. A comprehensive 2017 review in Cannabis and Cannabinoid Research concluded that CBD has a favourable safety profile, with most adverse effects being mild. (Iffland & Grotenhermen, 2017)

Common side effects may include fatigue, changes in appetite, dry mouth, and diarrhoea — typically at higher doses. These effects are usually temporary and resolve when the dose is reduced.

Drug interactions

This is the most important safety consideration. CBD inhibits certain cytochrome P450 enzymes (particularly CYP3A4 and CYP2C19), which are responsible for metabolising a significant number of prescription medications. This means CBD can increase or decrease the effectiveness of other drugs.

Medications that carry particular interaction risks include blood thinners (warfarin), certain anti-epileptic drugs, immunosuppressants, and some antidepressants. If you take any prescription medication, consult your doctor before using CBD. This isn't a generic disclaimer — it's genuinely important.

Who should avoid CBD

Based on current evidence and EFSA's precautionary guidance, the following groups should exercise extra caution or avoid CBD supplements:

• Pregnant or breastfeeding women
• People under 25 (due to insufficient safety data)
• Anyone taking medications metabolised by CYP3A4 or CYP2C19
• People with severe liver disease
• Anyone scheduled for surgery (CBD may affect blood clotting)

---

Getting Started with CBD: A Practical Guide

If you've decided to try CBD, here's a sensible approach.

Start with a low dose. Begin with 10-15mg of CBD per day. If you're using a standard 10ml bottle of 5% CBD oil, this is roughly 3-5 drops. Take it sublingually — hold it under your tongue for 60-90 seconds before swallowing to maximise absorption.

Give it time. Unlike a painkiller, CBD doesn't typically produce dramatic instant effects. Most people notice changes in anxiety and sleep quality within the first one to two weeks, but some benefits — particularly those related to inflammation — may take four to six weeks to become apparent.

Increase gradually. If you don't notice effects after a week, increase your dose by 5mg and hold for another week. Most studies showing benefits use doses between 25-75mg per day for general wellness, though some clinical applications use much higher doses under medical supervision.

Keep a simple journal. Track your dose, the time you take it, and note any changes in the areas you're targeting — sleep quality, anxiety levels, pain, or whatever your goal is. This makes it much easier to identify what's working.

Choose your timing. If you're using CBD for sleep, take it 30-60 minutes before bed. For daytime anxiety, a morning dose or split morning/evening dose works well. CBD taken with food (especially food containing healthy fats) tends to absorb better.

Be consistent. CBD appears to work best with regular use. Think of it more like a daily supplement than an on-demand medication.

---

Frequently Asked Questions

Does CBD get you high?

No. CBD is non-intoxicating. It does not produce the psychoactive effects associated with THC. Full-spectrum products contain trace amounts of THC (below 0.2% in the EU), but this is not enough to cause any intoxicating effect.

How long does CBD take to work?

It depends on the format. Sublingual oils typically take 15-25 minutes. Capsules and edibles take 30-90 minutes. Topicals may take 15-45 minutes for localised effects. Vapes act within minutes.

Can CBD show up on a drug test?

Pure CBD should not trigger a standard drug test, which typically screens for THC metabolites. However, full-spectrum products contain trace THC, and in theory, very high doses used consistently could cause a positive result — though this is rare at normal supplemental doses.

How much CBD should I take?

There's no universal dose. Start with 10-15mg per day and increase gradually. Most people find their effective dose somewhere between 25-75mg daily. See our CBD Dosage Guide for a more detailed framework.

Can I take CBD with other supplements?

CBD pairs well with many supplements, including magnesium, L-theanine, and omega-3 fatty acids. However, due to enzyme interactions, be cautious combining CBD with other supplements that affect liver metabolism. See our guide to Supplement and Drug Interactions for more detail.

---

Where to Go from Here

CBD is one piece of a larger wellness puzzle. It's not magic, but for the right person and the right use case — particularly anxiety and sleep — the evidence is encouraging enough to justify a thoughtful trial.

If you want to dive deeper into specific aspects of CBD, we've written focused guides on the topics that matter most:

• CBD Oil vs CBD Capsules: Which Is Better for You?
• Full-Spectrum vs Broad-Spectrum vs CBD Isolate
• CBD for Sleep: How It Works and What to Expect
• How to Choose the Right CBD Dosage

---

This article is for informational purposes only and is not intended as medical advice. Always consult a healthcare professional before starting any new supplement, especially if you take prescription medication.

Last updated: February 2026